| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.5 |